Global Intravenous Immunoglobulin(IVIg) Therapy Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
The global market for Intravenous Immunoglobulin(IVIg) Therapy is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Intravenous Immunoglobulin(IVIg) Therapy market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Intravenous Immunoglobulin(IVIg) Therapy market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Intravenous Immunoglobulin(IVIg) Therapy market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Intravenous Immunoglobulin(IVIg) Therapy market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Intravenous Immunoglobulin(IVIg) Therapy players cover TEIJIN LIMITED, Grifols, Biotest, Kamada and Takeda, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Intravenous Immunoglobulin(IVIg) Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Intravenous Immunoglobulin(IVIg) Therapy market, with both quantitative and qualitative data, to help readers understand how the Intravenous Immunoglobulin(IVIg) Therapy market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Intravenous Immunoglobulin(IVIg) Therapy market and forecasts the market size by Type (1g/20ml, 1.25g/25ml and 2.5g/50ml), by Application (Immunodeficiency, Autoimmune Disease, Acute Infection and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
Chapter 1: Scope of Intravenous Immunoglobulin(IVIg) Therapy, Research Methodology, etc.
Chapter 2: Executive Summary, global Intravenous Immunoglobulin(IVIg) Therapy market size (sales and revenue) and CAGR, Intravenous Immunoglobulin(IVIg) Therapy market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Intravenous Immunoglobulin(IVIg) Therapy sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Intravenous Immunoglobulin(IVIg) Therapy sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Intravenous Immunoglobulin(IVIg) Therapy market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including TEIJIN LIMITED, Grifols, Biotest, Kamada, Takeda, Octapharma, Kedrion, LFB Group and Baxter, etc.
Chapter 14: Research Findings and Conclusion
The global market for Intravenous Immunoglobulin(IVIg) Therapy is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Intravenous Immunoglobulin(IVIg) Therapy market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Intravenous Immunoglobulin(IVIg) Therapy market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Intravenous Immunoglobulin(IVIg) Therapy market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Intravenous Immunoglobulin(IVIg) Therapy market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Intravenous Immunoglobulin(IVIg) Therapy players cover TEIJIN LIMITED, Grifols, Biotest, Kamada and Takeda, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Intravenous Immunoglobulin(IVIg) Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Intravenous Immunoglobulin(IVIg) Therapy market, with both quantitative and qualitative data, to help readers understand how the Intravenous Immunoglobulin(IVIg) Therapy market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in K Units.
Market Segmentation:
The study segments the Intravenous Immunoglobulin(IVIg) Therapy market and forecasts the market size by Type (1g/20ml, 1.25g/25ml and 2.5g/50ml), by Application (Immunodeficiency, Autoimmune Disease, Acute Infection and Others), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
- 1g/20ml
- 1.25g/25ml
- 2.5g/50ml
- 5g/100ml
- 10g/200ml
- Others
- Immunodeficiency
- Autoimmune Disease
- Acute Infection
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- TEIJIN LIMITED
- Grifols
- Biotest
- Kamada
- Takeda
- Octapharma
- Kedrion
- LFB Group
- Baxter
- Nanyue Biopharming
- Boya-Bio
- CSL Plasma
- CNBG
- Beijing Tiantan Biological Products
- Hualan Bio
- Guangdong Shuagnlin Bio-pharmacy
- Weiguang Biological
- Sinopharm
- Shanghai RAAS
- Taibang Biologic Group
Chapter 1: Scope of Intravenous Immunoglobulin(IVIg) Therapy, Research Methodology, etc.
Chapter 2: Executive Summary, global Intravenous Immunoglobulin(IVIg) Therapy market size (sales and revenue) and CAGR, Intravenous Immunoglobulin(IVIg) Therapy market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Intravenous Immunoglobulin(IVIg) Therapy sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Intravenous Immunoglobulin(IVIg) Therapy sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by type, and type.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Intravenous Immunoglobulin(IVIg) Therapy market size forecast by region, by country, by type, and application.
Chapter 13: Comprehensive company profiles of the leading players, including TEIJIN LIMITED, Grifols, Biotest, Kamada, Takeda, Octapharma, Kedrion, LFB Group and Baxter, etc.
Chapter 14: Research Findings and Conclusion
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Intravenous Immunoglobulin(IVIg) Therapy by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Intravenous Immunoglobulin(IVIg) Therapy by Country/Region, 2017, 2022 & 2028
2.2 Intravenous Immunoglobulin(IVIg) Therapy Segment by Type
2.2.1 1g/20ml
2.2.2 1.25g/25ml
2.2.3 2.5g/50ml
2.2.4 5g/100ml
2.2.5 10g/200ml
2.2.6 Others
2.3 Intravenous Immunoglobulin(IVIg) Therapy Sales by Type
2.3.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2017-2022)
2.3.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue and Market Share by Type (2017-2022)
2.3.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Type (2017-2022)
2.4 Intravenous Immunoglobulin(IVIg) Therapy Segment by Application
2.4.1 Immunodeficiency
2.4.2 Autoimmune Disease
2.4.3 Acute Infection
2.4.4 Others
2.5 Intravenous Immunoglobulin(IVIg) Therapy Sales by Application
2.5.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sale Market Share by Application (2017-2022)
2.5.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue and Market Share by Application (2017-2022)
2.5.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Application (2017-2022)
3 GLOBAL INTRAVENOUS IMMUNOGLOBULIN(IVIG) THERAPY BY COMPANY
3.1 Global Intravenous Immunoglobulin(IVIg) Therapy Breakdown Data by Company
3.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Sales by Company (2020-2022)
3.1.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Company (2020-2022)
3.2 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Revenue by Company (2020-2022)
3.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Company (2020-2022)
3.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Company (2020-2022)
3.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Company
3.4 Key Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Product Location Distribution
3.4.2 Players Intravenous Immunoglobulin(IVIg) Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INTRAVENOUS IMMUNOGLOBULIN(IVIG) THERAPY BY GEOGRAPHIC REGION
4.1 World Historic Intravenous Immunoglobulin(IVIg) Therapy Market Size by Geographic Region (2017-2022)
4.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Revenue by Geographic Region
4.2 World Historic Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country/Region (2017-2022)
4.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Sales by Country/Region (2017-2022)
4.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Revenue by Country/Region
4.3 Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Growth
4.4 APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Growth
4.5 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Growth
4.6 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Growth
5 AMERICAS
5.1 Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Country
5.1.1 Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2017-2022)
5.1.2 Americas Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2017-2022)
5.2 Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Type
5.3 Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Region
6.1.1 APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2017-2022)
6.1.2 APAC Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2017-2022)
6.2 APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Type
6.3 APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Intravenous Immunoglobulin(IVIg) Therapy by Country
7.1.1 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2017-2022)
7.1.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2017-2022)
7.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Type
7.3 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy by Country
8.1.1 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2017-2022)
8.1.2 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2017-2022)
8.2 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Type
8.3 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravenous Immunoglobulin(IVIg) Therapy
10.3 Manufacturing Process Analysis of Intravenous Immunoglobulin(IVIg) Therapy
10.4 Industry Chain Structure of Intravenous Immunoglobulin(IVIg) Therapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravenous Immunoglobulin(IVIg) Therapy Distributors
11.3 Intravenous Immunoglobulin(IVIg) Therapy Customer
12 WORLD FORECAST REVIEW FOR INTRAVENOUS IMMUNOGLOBULIN(IVIG) THERAPY BY GEOGRAPHIC REGION
12.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Forecast by Region
12.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Forecast by Region (2023-2028)
12.1.2 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intravenous Immunoglobulin(IVIg) Therapy Forecast by Type
12.7 Global Intravenous Immunoglobulin(IVIg) Therapy Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 TEIJIN LIMITED
13.1.1 TEIJIN LIMITED Company Information
13.1.2 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.1.3 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 TEIJIN LIMITED Main Business Overview
13.1.5 TEIJIN LIMITED Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.2.3 Grifols Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Biotest
13.3.1 Biotest Company Information
13.3.2 Biotest Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.3.3 Biotest Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Biotest Main Business Overview
13.3.5 Biotest Latest Developments
13.4 Kamada
13.4.1 Kamada Company Information
13.4.2 Kamada Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.4.3 Kamada Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Kamada Main Business Overview
13.4.5 Kamada Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.5.3 Takeda Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
13.6 Octapharma
13.6.1 Octapharma Company Information
13.6.2 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.6.3 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Octapharma Main Business Overview
13.6.5 Octapharma Latest Developments
13.7 Kedrion
13.7.1 Kedrion Company Information
13.7.2 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.7.3 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Kedrion Main Business Overview
13.7.5 Kedrion Latest Developments
13.8 LFB Group
13.8.1 LFB Group Company Information
13.8.2 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.8.3 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 LFB Group Main Business Overview
13.8.5 LFB Group Latest Developments
13.9 Baxter
13.9.1 Baxter Company Information
13.9.2 Baxter Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.9.3 Baxter Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Baxter Main Business Overview
13.9.5 Baxter Latest Developments
13.10 Nanyue Biopharming
13.10.1 Nanyue Biopharming Company Information
13.10.2 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.10.3 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Nanyue Biopharming Main Business Overview
13.10.5 Nanyue Biopharming Latest Developments
13.11 Boya-Bio
13.11.1 Boya-Bio Company Information
13.11.2 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.11.3 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Boya-Bio Main Business Overview
13.11.5 Boya-Bio Latest Developments
13.12 CSL Plasma
13.12.1 CSL Plasma Company Information
13.12.2 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.12.3 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 CSL Plasma Main Business Overview
13.12.5 CSL Plasma Latest Developments
13.13 CNBG
13.13.1 CNBG Company Information
13.13.2 CNBG Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.13.3 CNBG Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 CNBG Main Business Overview
13.13.5 CNBG Latest Developments
13.14 Beijing Tiantan Biological Products
13.14.1 Beijing Tiantan Biological Products Company Information
13.14.2 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.14.3 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Beijing Tiantan Biological Products Main Business Overview
13.14.5 Beijing Tiantan Biological Products Latest Developments
13.15 Hualan Bio
13.15.1 Hualan Bio Company Information
13.15.2 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.15.3 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Hualan Bio Main Business Overview
13.15.5 Hualan Bio Latest Developments
13.16 Guangdong Shuagnlin Bio-pharmacy
13.16.1 Guangdong Shuagnlin Bio-pharmacy Company Information
13.16.2 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.16.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Guangdong Shuagnlin Bio-pharmacy Main Business Overview
13.16.5 Guangdong Shuagnlin Bio-pharmacy Latest Developments
13.17 Weiguang Biological
13.17.1 Weiguang Biological Company Information
13.17.2 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.17.3 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Weiguang Biological Main Business Overview
13.17.5 Weiguang Biological Latest Developments
13.18 Sinopharm
13.18.1 Sinopharm Company Information
13.18.2 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.18.3 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Sinopharm Main Business Overview
13.18.5 Sinopharm Latest Developments
13.19 Shanghai RAAS
13.19.1 Shanghai RAAS Company Information
13.19.2 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.19.3 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Shanghai RAAS Main Business Overview
13.19.5 Shanghai RAAS Latest Developments
13.20 Taibang Biologic Group
13.20.1 Taibang Biologic Group Company Information
13.20.2 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.20.3 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Taibang Biologic Group Main Business Overview
13.20.5 Taibang Biologic Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Intravenous Immunoglobulin(IVIg) Therapy by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Intravenous Immunoglobulin(IVIg) Therapy by Country/Region, 2017, 2022 & 2028
2.2 Intravenous Immunoglobulin(IVIg) Therapy Segment by Type
2.2.1 1g/20ml
2.2.2 1.25g/25ml
2.2.3 2.5g/50ml
2.2.4 5g/100ml
2.2.5 10g/200ml
2.2.6 Others
2.3 Intravenous Immunoglobulin(IVIg) Therapy Sales by Type
2.3.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2017-2022)
2.3.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue and Market Share by Type (2017-2022)
2.3.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Type (2017-2022)
2.4 Intravenous Immunoglobulin(IVIg) Therapy Segment by Application
2.4.1 Immunodeficiency
2.4.2 Autoimmune Disease
2.4.3 Acute Infection
2.4.4 Others
2.5 Intravenous Immunoglobulin(IVIg) Therapy Sales by Application
2.5.1 Global Intravenous Immunoglobulin(IVIg) Therapy Sale Market Share by Application (2017-2022)
2.5.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue and Market Share by Application (2017-2022)
2.5.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Application (2017-2022)
3 GLOBAL INTRAVENOUS IMMUNOGLOBULIN(IVIG) THERAPY BY COMPANY
3.1 Global Intravenous Immunoglobulin(IVIg) Therapy Breakdown Data by Company
3.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Sales by Company (2020-2022)
3.1.2 Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Company (2020-2022)
3.2 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Revenue by Company (2020-2022)
3.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Company (2020-2022)
3.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Company (2020-2022)
3.3 Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Company
3.4 Key Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Product Location Distribution
3.4.2 Players Intravenous Immunoglobulin(IVIg) Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR INTRAVENOUS IMMUNOGLOBULIN(IVIG) THERAPY BY GEOGRAPHIC REGION
4.1 World Historic Intravenous Immunoglobulin(IVIg) Therapy Market Size by Geographic Region (2017-2022)
4.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Revenue by Geographic Region
4.2 World Historic Intravenous Immunoglobulin(IVIg) Therapy Market Size by Country/Region (2017-2022)
4.2.1 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Sales by Country/Region (2017-2022)
4.2.2 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Revenue by Country/Region
4.3 Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Growth
4.4 APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Growth
4.5 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Growth
4.6 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Growth
5 AMERICAS
5.1 Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Country
5.1.1 Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2017-2022)
5.1.2 Americas Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2017-2022)
5.2 Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Type
5.3 Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Region
6.1.1 APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2017-2022)
6.1.2 APAC Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2017-2022)
6.2 APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Type
6.3 APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Intravenous Immunoglobulin(IVIg) Therapy by Country
7.1.1 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2017-2022)
7.1.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2017-2022)
7.2 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Type
7.3 Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy by Country
8.1.1 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2017-2022)
8.1.2 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2017-2022)
8.2 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Type
8.3 Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravenous Immunoglobulin(IVIg) Therapy
10.3 Manufacturing Process Analysis of Intravenous Immunoglobulin(IVIg) Therapy
10.4 Industry Chain Structure of Intravenous Immunoglobulin(IVIg) Therapy
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravenous Immunoglobulin(IVIg) Therapy Distributors
11.3 Intravenous Immunoglobulin(IVIg) Therapy Customer
12 WORLD FORECAST REVIEW FOR INTRAVENOUS IMMUNOGLOBULIN(IVIG) THERAPY BY GEOGRAPHIC REGION
12.1 Global Intravenous Immunoglobulin(IVIg) Therapy Market Size Forecast by Region
12.1.1 Global Intravenous Immunoglobulin(IVIg) Therapy Forecast by Region (2023-2028)
12.1.2 Global Intravenous Immunoglobulin(IVIg) Therapy Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Intravenous Immunoglobulin(IVIg) Therapy Forecast by Type
12.7 Global Intravenous Immunoglobulin(IVIg) Therapy Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 TEIJIN LIMITED
13.1.1 TEIJIN LIMITED Company Information
13.1.2 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.1.3 TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 TEIJIN LIMITED Main Business Overview
13.1.5 TEIJIN LIMITED Latest Developments
13.2 Grifols
13.2.1 Grifols Company Information
13.2.2 Grifols Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.2.3 Grifols Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Grifols Main Business Overview
13.2.5 Grifols Latest Developments
13.3 Biotest
13.3.1 Biotest Company Information
13.3.2 Biotest Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.3.3 Biotest Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Biotest Main Business Overview
13.3.5 Biotest Latest Developments
13.4 Kamada
13.4.1 Kamada Company Information
13.4.2 Kamada Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.4.3 Kamada Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Kamada Main Business Overview
13.4.5 Kamada Latest Developments
13.5 Takeda
13.5.1 Takeda Company Information
13.5.2 Takeda Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.5.3 Takeda Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Takeda Main Business Overview
13.5.5 Takeda Latest Developments
13.6 Octapharma
13.6.1 Octapharma Company Information
13.6.2 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.6.3 Octapharma Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Octapharma Main Business Overview
13.6.5 Octapharma Latest Developments
13.7 Kedrion
13.7.1 Kedrion Company Information
13.7.2 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.7.3 Kedrion Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Kedrion Main Business Overview
13.7.5 Kedrion Latest Developments
13.8 LFB Group
13.8.1 LFB Group Company Information
13.8.2 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.8.3 LFB Group Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 LFB Group Main Business Overview
13.8.5 LFB Group Latest Developments
13.9 Baxter
13.9.1 Baxter Company Information
13.9.2 Baxter Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.9.3 Baxter Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Baxter Main Business Overview
13.9.5 Baxter Latest Developments
13.10 Nanyue Biopharming
13.10.1 Nanyue Biopharming Company Information
13.10.2 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.10.3 Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Nanyue Biopharming Main Business Overview
13.10.5 Nanyue Biopharming Latest Developments
13.11 Boya-Bio
13.11.1 Boya-Bio Company Information
13.11.2 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.11.3 Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Boya-Bio Main Business Overview
13.11.5 Boya-Bio Latest Developments
13.12 CSL Plasma
13.12.1 CSL Plasma Company Information
13.12.2 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.12.3 CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 CSL Plasma Main Business Overview
13.12.5 CSL Plasma Latest Developments
13.13 CNBG
13.13.1 CNBG Company Information
13.13.2 CNBG Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.13.3 CNBG Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 CNBG Main Business Overview
13.13.5 CNBG Latest Developments
13.14 Beijing Tiantan Biological Products
13.14.1 Beijing Tiantan Biological Products Company Information
13.14.2 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.14.3 Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Beijing Tiantan Biological Products Main Business Overview
13.14.5 Beijing Tiantan Biological Products Latest Developments
13.15 Hualan Bio
13.15.1 Hualan Bio Company Information
13.15.2 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.15.3 Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Hualan Bio Main Business Overview
13.15.5 Hualan Bio Latest Developments
13.16 Guangdong Shuagnlin Bio-pharmacy
13.16.1 Guangdong Shuagnlin Bio-pharmacy Company Information
13.16.2 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.16.3 Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Guangdong Shuagnlin Bio-pharmacy Main Business Overview
13.16.5 Guangdong Shuagnlin Bio-pharmacy Latest Developments
13.17 Weiguang Biological
13.17.1 Weiguang Biological Company Information
13.17.2 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.17.3 Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Weiguang Biological Main Business Overview
13.17.5 Weiguang Biological Latest Developments
13.18 Sinopharm
13.18.1 Sinopharm Company Information
13.18.2 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.18.3 Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Sinopharm Main Business Overview
13.18.5 Sinopharm Latest Developments
13.19 Shanghai RAAS
13.19.1 Shanghai RAAS Company Information
13.19.2 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.19.3 Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Shanghai RAAS Main Business Overview
13.19.5 Shanghai RAAS Latest Developments
13.20 Taibang Biologic Group
13.20.1 Taibang Biologic Group Company Information
13.20.2 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product Offered
13.20.3 Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Taibang Biologic Group Main Business Overview
13.20.5 Taibang Biologic Group Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Intravenous Immunoglobulin(IVIg) Therapy Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Intravenous Immunoglobulin(IVIg) Therapy Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 1g/20ml
Table 4. Major Players of 1.25g/25ml
Table 5. Major Players of 2.5g/50ml
Table 6. Major Players of 5g/100ml
Table 7. Major Players of 10g/200ml
Table 8. Major Players of Others
Table 9. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2017-2022) & (K Units)
Table 10. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2017-2022)
Table 11. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2017-2022) & ($ million)
Table 12. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Type (2017-2022)
Table 13. Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Type (2017-2022) & (US$/Unit)
Table 14. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2017-2022) & (K Units)
Table 15. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2017-2022)
Table 16. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2017-2022)
Table 17. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Application (2017-2022)
Table 18. Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Application (2017-2022) & (US$/Unit)
Table 19. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Company (2020-2022) & (K Units)
Table 20. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Company (2020-2022)
Table 21. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Company (2020-2022)
Table 23. Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Company (2020-2022) & (US$/Unit)
Table 24. Key Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Producing Area Distribution and Sales Area
Table 25. Players Intravenous Immunoglobulin(IVIg) Therapy Products Offered
Table 26. Intravenous Immunoglobulin(IVIg) Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Geographic Region (2017-2022) & (K Units)
Table 30. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share Geographic Region (2017-2022)
Table 31. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Country/Region (2017-2022) & (K Units)
Table 34. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country/Region (2017-2022)
Table 35. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2017-2022) & (K Units)
Table 38. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2017-2022)
Table 39. Americas Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2017-2022)
Table 41. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2017-2022) & (K Units)
Table 42. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2017-2022)
Table 43. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2017-2022) & (K Units)
Table 44. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2017-2022)
Table 45. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2017-2022) & (K Units)
Table 46. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region (2017-2022)
Table 47. APAC Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Region (2017-2022)
Table 49. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2017-2022) & (K Units)
Table 50. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2017-2022)
Table 51. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2017-2022) & (K Units)
Table 52. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2017-2022)
Table 53. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2017-2022) & (K Units)
Table 54. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2017-2022)
Table 55. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2017-2022)
Table 57. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2017-2022) & (K Units)
Table 58. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2017-2022)
Table 59. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2017-2022) & (K Units)
Table 60. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2017-2022) & (K Units)
Table 62. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2017-2022) & (K Units)
Table 66. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2017-2022) & (K Units)
Table 68. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Intravenous Immunoglobulin(IVIg) Therapy
Table 70. Key Market Challenges & Risks of Intravenous Immunoglobulin(IVIg) Therapy
Table 71. Key Industry Trends of Intravenous Immunoglobulin(IVIg) Therapy
Table 72. Intravenous Immunoglobulin(IVIg) Therapy Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Intravenous Immunoglobulin(IVIg) Therapy Distributors List
Table 75. Intravenous Immunoglobulin(IVIg) Therapy Customer List
Table 76. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Region (2023-2028) & (K Units)
Table 77. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Forecast by Region
Table 78. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Americas Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Region (2023-2028) & (K Units)
Table 83. APAC Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2023-2028) & (K Units)
Table 87. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Type (2023-2028) & (K Units)
Table 89. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Application (2023-2028) & (K Units)
Table 93. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share Forecast by Application (2023-2028)
Table 96. TEIJIN LIMITED Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 97. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 98. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 99. TEIJIN LIMITED Main Business
Table 100. TEIJIN LIMITED Latest Developments
Table 101. Grifols Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 102. Grifols Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 103. Grifols Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 104. Grifols Main Business
Table 105. Grifols Latest Developments
Table 106. Biotest Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 107. Biotest Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 108. Biotest Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 109. Biotest Main Business
Table 110. Biotest Latest Developments
Table 111. Kamada Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 112. Kamada Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 113. Kamada Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 114. Kamada Main Business
Table 115. Kamada Latest Developments
Table 116. Takeda Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 117. Takeda Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 118. Takeda Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 119. Takeda Main Business
Table 120. Takeda Latest Developments
Table 121. Octapharma Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 122. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 123. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 124. Octapharma Main Business
Table 125. Octapharma Latest Developments
Table 126. Kedrion Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 127. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 128. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 129. Kedrion Main Business
Table 130. Kedrion Latest Developments
Table 131. LFB Group Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 132. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 133. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 134. LFB Group Main Business
Table 135. LFB Group Latest Developments
Table 136. Baxter Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 137. Baxter Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 138. Baxter Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 139. Baxter Main Business
Table 140. Baxter Latest Developments
Table 141. Nanyue Biopharming Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 142. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 143. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 144. Nanyue Biopharming Main Business
Table 145. Nanyue Biopharming Latest Developments
Table 146. Boya-Bio Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 147. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 148. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 149. Boya-Bio Main Business
Table 150. Boya-Bio Latest Developments
Table 151. CSL Plasma Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 152. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 153. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 154. CSL Plasma Main Business
Table 155. CSL Plasma Latest Developments
Table 156. CNBG Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 157. CNBG Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 158. CNBG Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 159. CNBG Main Business
Table 160. CNBG Latest Developments
Table 161. Beijing Tiantan Biological Products Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 162. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 163. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 164. Beijing Tiantan Biological Products Main Business
Table 165. Beijing Tiantan Biological Products Latest Developments
Table 166. Hualan Bio Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 167. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 168. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 169. Hualan Bio Main Business
Table 170. Hualan Bio Latest Developments
Table 171. Guangdong Shuagnlin Bio-pharmacy Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 172. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 173. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 174. Guangdong Shuagnlin Bio-pharmacy Main Business
Table 175. Guangdong Shuagnlin Bio-pharmacy Latest Developments
Table 176. Weiguang Biological Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 177. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 178. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 179. Weiguang Biological Main Business
Table 180. Weiguang Biological Latest Developments
Table 181. Sinopharm Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 182. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 183. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 184. Sinopharm Main Business
Table 185. Sinopharm Latest Developments
Table 186. Shanghai RAAS Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 187. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 188. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 189. Shanghai RAAS Main Business
Table 190. Shanghai RAAS Latest Developments
Table 191. Taibang Biologic Group Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 192. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 193. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 194. Taibang Biologic Group Main Business
Table 195. Taibang Biologic Group Latest Developments
Table 1. Intravenous Immunoglobulin(IVIg) Therapy Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Intravenous Immunoglobulin(IVIg) Therapy Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 1g/20ml
Table 4. Major Players of 1.25g/25ml
Table 5. Major Players of 2.5g/50ml
Table 6. Major Players of 5g/100ml
Table 7. Major Players of 10g/200ml
Table 8. Major Players of Others
Table 9. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2017-2022) & (K Units)
Table 10. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2017-2022)
Table 11. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Type (2017-2022) & ($ million)
Table 12. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Type (2017-2022)
Table 13. Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Type (2017-2022) & (US$/Unit)
Table 14. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2017-2022) & (K Units)
Table 15. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2017-2022)
Table 16. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Application (2017-2022)
Table 17. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Application (2017-2022)
Table 18. Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Application (2017-2022) & (US$/Unit)
Table 19. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Company (2020-2022) & (K Units)
Table 20. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Company (2020-2022)
Table 21. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Company (2020-2022)
Table 23. Global Intravenous Immunoglobulin(IVIg) Therapy Sale Price by Company (2020-2022) & (US$/Unit)
Table 24. Key Manufacturers Intravenous Immunoglobulin(IVIg) Therapy Producing Area Distribution and Sales Area
Table 25. Players Intravenous Immunoglobulin(IVIg) Therapy Products Offered
Table 26. Intravenous Immunoglobulin(IVIg) Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Geographic Region (2017-2022) & (K Units)
Table 30. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share Geographic Region (2017-2022)
Table 31. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Country/Region (2017-2022) & (K Units)
Table 34. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country/Region (2017-2022)
Table 35. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2017-2022) & (K Units)
Table 38. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2017-2022)
Table 39. Americas Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2017-2022)
Table 41. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2017-2022) & (K Units)
Table 42. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2017-2022)
Table 43. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2017-2022) & (K Units)
Table 44. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2017-2022)
Table 45. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2017-2022) & (K Units)
Table 46. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region (2017-2022)
Table 47. APAC Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Region (2017-2022)
Table 49. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2017-2022) & (K Units)
Table 50. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2017-2022)
Table 51. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2017-2022) & (K Units)
Table 52. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2017-2022)
Table 53. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2017-2022) & (K Units)
Table 54. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2017-2022)
Table 55. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2017-2022)
Table 57. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2017-2022) & (K Units)
Table 58. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2017-2022)
Table 59. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2017-2022) & (K Units)
Table 60. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2017-2022) & (K Units)
Table 62. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Type (2017-2022) & (K Units)
Table 66. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Application (2017-2022) & (K Units)
Table 68. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Intravenous Immunoglobulin(IVIg) Therapy
Table 70. Key Market Challenges & Risks of Intravenous Immunoglobulin(IVIg) Therapy
Table 71. Key Industry Trends of Intravenous Immunoglobulin(IVIg) Therapy
Table 72. Intravenous Immunoglobulin(IVIg) Therapy Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Intravenous Immunoglobulin(IVIg) Therapy Distributors List
Table 75. Intravenous Immunoglobulin(IVIg) Therapy Customer List
Table 76. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Region (2023-2028) & (K Units)
Table 77. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Forecast by Region
Table 78. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Americas Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Region (2023-2028) & (K Units)
Table 83. APAC Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Country (2023-2028) & (K Units)
Table 87. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Type (2023-2028) & (K Units)
Table 89. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Forecast by Application (2023-2028) & (K Units)
Table 93. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share Forecast by Application (2023-2028)
Table 96. TEIJIN LIMITED Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 97. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 98. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 99. TEIJIN LIMITED Main Business
Table 100. TEIJIN LIMITED Latest Developments
Table 101. Grifols Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 102. Grifols Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 103. Grifols Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 104. Grifols Main Business
Table 105. Grifols Latest Developments
Table 106. Biotest Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 107. Biotest Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 108. Biotest Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 109. Biotest Main Business
Table 110. Biotest Latest Developments
Table 111. Kamada Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 112. Kamada Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 113. Kamada Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 114. Kamada Main Business
Table 115. Kamada Latest Developments
Table 116. Takeda Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 117. Takeda Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 118. Takeda Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 119. Takeda Main Business
Table 120. Takeda Latest Developments
Table 121. Octapharma Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 122. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 123. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 124. Octapharma Main Business
Table 125. Octapharma Latest Developments
Table 126. Kedrion Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 127. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 128. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 129. Kedrion Main Business
Table 130. Kedrion Latest Developments
Table 131. LFB Group Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 132. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 133. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 134. LFB Group Main Business
Table 135. LFB Group Latest Developments
Table 136. Baxter Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 137. Baxter Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 138. Baxter Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 139. Baxter Main Business
Table 140. Baxter Latest Developments
Table 141. Nanyue Biopharming Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 142. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 143. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 144. Nanyue Biopharming Main Business
Table 145. Nanyue Biopharming Latest Developments
Table 146. Boya-Bio Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 147. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 148. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 149. Boya-Bio Main Business
Table 150. Boya-Bio Latest Developments
Table 151. CSL Plasma Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 152. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 153. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 154. CSL Plasma Main Business
Table 155. CSL Plasma Latest Developments
Table 156. CNBG Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 157. CNBG Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 158. CNBG Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 159. CNBG Main Business
Table 160. CNBG Latest Developments
Table 161. Beijing Tiantan Biological Products Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 162. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 163. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 164. Beijing Tiantan Biological Products Main Business
Table 165. Beijing Tiantan Biological Products Latest Developments
Table 166. Hualan Bio Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 167. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 168. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 169. Hualan Bio Main Business
Table 170. Hualan Bio Latest Developments
Table 171. Guangdong Shuagnlin Bio-pharmacy Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 172. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 173. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 174. Guangdong Shuagnlin Bio-pharmacy Main Business
Table 175. Guangdong Shuagnlin Bio-pharmacy Latest Developments
Table 176. Weiguang Biological Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 177. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 178. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 179. Weiguang Biological Main Business
Table 180. Weiguang Biological Latest Developments
Table 181. Sinopharm Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 182. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 183. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 184. Sinopharm Main Business
Table 185. Sinopharm Latest Developments
Table 186. Shanghai RAAS Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 187. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 188. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 189. Shanghai RAAS Main Business
Table 190. Shanghai RAAS Latest Developments
Table 191. Taibang Biologic Group Basic Information, Intravenous Immunoglobulin(IVIg) Therapy Manufacturing Base, Sales Area and Its Competitors
Table 192. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product Offered
Table 193. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 194. Taibang Biologic Group Main Business
Table 195. Taibang Biologic Group Latest Developments
LIST OF FIGURES
Figure 1. Picture of Intravenous Immunoglobulin(IVIg) Therapy
Figure 2. Intravenous Immunoglobulin(IVIg) Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 1g/20ml
Figure 10. Product Picture of 1.25g/25ml
Figure 11. Product Picture of 2.5g/50ml
Figure 12. Product Picture of 5g/100ml
Figure 13. Product Picture of 10g/200ml
Figure 14. Product Picture of Others
Figure 15. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type in 2021
Figure 16. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Type (2017-2022)
Figure 17. Intravenous Immunoglobulin(IVIg) Therapy Consumed in Immunodeficiency
Figure 18. Global Intravenous Immunoglobulin(IVIg) Therapy Market: Immunodeficiency (2017-2022) & (K Units)
Figure 19. Intravenous Immunoglobulin(IVIg) Therapy Consumed in Autoimmune Disease
Figure 20. Global Intravenous Immunoglobulin(IVIg) Therapy Market: Autoimmune Disease (2017-2022) & (K Units)
Figure 21. Intravenous Immunoglobulin(IVIg) Therapy Consumed in Acute Infection
Figure 22. Global Intravenous Immunoglobulin(IVIg) Therapy Market: Acute Infection (2017-2022) & (K Units)
Figure 23. Intravenous Immunoglobulin(IVIg) Therapy Consumed in Others
Figure 24. Global Intravenous Immunoglobulin(IVIg) Therapy Market: Others (2017-2022) & (K Units)
Figure 25. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2017-2022)
Figure 26. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Application in 2021
Figure 27. Intravenous Immunoglobulin(IVIg) Therapy Revenue Market by Company in 2021 ($ Million)
Figure 28. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Company in 2021
Figure 29. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Geographic Region in 2021
Figure 31. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region (2017-2022)
Figure 32. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country/Region in 2021
Figure 33. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales 2017-2022 (K Units)
Figure 34. Americas Intravenous Immunoglobulin(IVIg) Therapy Revenue 2017-2022 ($ Millions)
Figure 35. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales 2017-2022 (K Units)
Figure 36. APAC Intravenous Immunoglobulin(IVIg) Therapy Revenue 2017-2022 ($ Millions)
Figure 37. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales 2017-2022 (K Units)
Figure 38. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales 2017-2022 (K Units)
Figure 40. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue 2017-2022 ($ Millions)
Figure 41. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country in 2021
Figure 42. Americas Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country in 2021
Figure 43. United States Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region in 2021
Figure 48. APAC Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Regions in 2021
Figure 49. China Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 53. India Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country in 2021
Figure 56. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country in 2021
Figure 57. Germany Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 58. France Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country in 2021
Figure 63. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country in 2021
Figure 64. Egypt Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of Intravenous Immunoglobulin(IVIg) Therapy in 2021
Figure 70. Manufacturing Process Analysis of Intravenous Immunoglobulin(IVIg) Therapy
Figure 71. Industry Chain Structure of Intravenous Immunoglobulin(IVIg) Therapy
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
Figure 1. Picture of Intravenous Immunoglobulin(IVIg) Therapy
Figure 2. Intravenous Immunoglobulin(IVIg) Therapy Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 1g/20ml
Figure 10. Product Picture of 1.25g/25ml
Figure 11. Product Picture of 2.5g/50ml
Figure 12. Product Picture of 5g/100ml
Figure 13. Product Picture of 10g/200ml
Figure 14. Product Picture of Others
Figure 15. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type in 2021
Figure 16. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Type (2017-2022)
Figure 17. Intravenous Immunoglobulin(IVIg) Therapy Consumed in Immunodeficiency
Figure 18. Global Intravenous Immunoglobulin(IVIg) Therapy Market: Immunodeficiency (2017-2022) & (K Units)
Figure 19. Intravenous Immunoglobulin(IVIg) Therapy Consumed in Autoimmune Disease
Figure 20. Global Intravenous Immunoglobulin(IVIg) Therapy Market: Autoimmune Disease (2017-2022) & (K Units)
Figure 21. Intravenous Immunoglobulin(IVIg) Therapy Consumed in Acute Infection
Figure 22. Global Intravenous Immunoglobulin(IVIg) Therapy Market: Acute Infection (2017-2022) & (K Units)
Figure 23. Intravenous Immunoglobulin(IVIg) Therapy Consumed in Others
Figure 24. Global Intravenous Immunoglobulin(IVIg) Therapy Market: Others (2017-2022) & (K Units)
Figure 25. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2017-2022)
Figure 26. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Application in 2021
Figure 27. Intravenous Immunoglobulin(IVIg) Therapy Revenue Market by Company in 2021 ($ Million)
Figure 28. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Company in 2021
Figure 29. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Geographic Region (2017-2022)
Figure 30. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Geographic Region in 2021
Figure 31. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region (2017-2022)
Figure 32. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country/Region in 2021
Figure 33. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales 2017-2022 (K Units)
Figure 34. Americas Intravenous Immunoglobulin(IVIg) Therapy Revenue 2017-2022 ($ Millions)
Figure 35. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales 2017-2022 (K Units)
Figure 36. APAC Intravenous Immunoglobulin(IVIg) Therapy Revenue 2017-2022 ($ Millions)
Figure 37. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales 2017-2022 (K Units)
Figure 38. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue 2017-2022 ($ Millions)
Figure 39. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales 2017-2022 (K Units)
Figure 40. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue 2017-2022 ($ Millions)
Figure 41. Americas Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country in 2021
Figure 42. Americas Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country in 2021
Figure 43. United States Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 44. Canada Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 45. Mexico Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 46. Brazil Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 47. APAC Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region in 2021
Figure 48. APAC Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Regions in 2021
Figure 49. China Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 50. Japan Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 51. South Korea Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 52. Southeast Asia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 53. India Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 54. Australia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 55. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country in 2021
Figure 56. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country in 2021
Figure 57. Germany Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 58. France Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 59. UK Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 60. Italy Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 61. Russia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 62. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country in 2021
Figure 63. Middle East & Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country in 2021
Figure 64. Egypt Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 65. South Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 66. Israel Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 67. Turkey Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 68. GCC Country Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth 2017-2022 ($ Millions)
Figure 69. Manufacturing Cost Structure Analysis of Intravenous Immunoglobulin(IVIg) Therapy in 2021
Figure 70. Manufacturing Process Analysis of Intravenous Immunoglobulin(IVIg) Therapy
Figure 71. Industry Chain Structure of Intravenous Immunoglobulin(IVIg) Therapy
Figure 72. Channels of Distribution
Figure 73. Distributors Profiles
